Discovery of 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications. (Q46460053)
Jump to navigation
Jump to search
scientific article published in May 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Discovery of 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications. |
scientific article published in May 2005 |
Statements
Discovery of 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications (English)
Michael C Van Zandt
Michael L Jones
David E Gunn
Leo S Geraci
J Howard Jones
Diane R Sawicki
Janet Sredy
Jorge L Jacot
A Thomas Dicioccio
Andre Mitschler